Comparing Neurodevelopmental Outcome among Neonates with Jaundice Due to ABO and Rh Incompatibility Comparing neurodevelopmental outcomes among neonates with jaundice
Iranian Journal of Child Neurology,
Vol. 20 No. 3 (2026),
1 June 2026
,
Page 63-69
https://doi.org/10.22037/ijcn.v20i3.45306
Abstract
Objectives:
Evaluating risk factors is essential in the context of hyperbilirubinemia and its clinical outcomes, particularly when attributed to its primary causes: maternal-fetal ABO and Rh incompatibility This study aims to determine the prevalence rate of predisposing factors and complications of hyperbilirubinemia in newborns with ABO blood group incompatibility, compared to those with Rh incompatibility.
Materials & Methods:
This is a descriptive-analytical study. The newborns with jaundice who were referred to Ghaem Teaching Hospital affiliated to the Mashhad University of Medical Sciences, Mashhad, Iran, from 2017 to 2019, divided into two groups of ABO incompatibility (n = 83) and Rh incompatibility (n = 81). The neurodevelopmental assessment was performed by Denver Developmental Screening Test II (DDST-II). Following that, a comparison was made between these two groups.
Results:
The mean age of the ABO incompatibility group was 5.84 days and the Rh incompatibility group was 4.91 days at admission time. The mean values of bilirubin level obtained at 28.26 ± 5.9 and 30.17 ± 8.19 in newborns with ABO and Rh incompatibility (P = 0.089). No significant difference was observed between the two groups regarding age, Apgar score, bilirubin level (P > 0.05), delivery type (χ2 = 1.56; P = 0.21), and gender (χ2 = 0.403; P = 0.52). Among the study population, 45.8% and 89.1% of the infants with Rh incompatibility and with ABO incompatibility had a near-normal neurological development in the first three years of life. A significant difference was found between the two groups regarding developmental status (χ2 = 25.13; P < 0.05).
Conclusion:
Despite similar bilirubin levels and treatment approaches, neonates with Rh incompatibility experienced significantly higher rates of developmental delay compared to those with ABO incompatibility. By age three, moderate to severe delays were more frequent in the Rh group, underscoring the greater neurodevelopmental risk associated with Rh-mediated hemolysis.
- Keywords: Incompatibility; Hyperbilirubinemia; Jaundice; Neurodevelopment; Neonatal
How to Cite
References
Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, Ebbesen F, Bell J, Mori R, Slusher TM, Fahmy N, Paul VK. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatric research. 2013 Dec;74(1):86-100.
Bhutani VK. For a safer outcome with newborn jaundice. Indian pediatrics. 2004 Apr 1;41(4):321-6.
Gharehbaghi MM, Ghasempour M, Heidarabadi S, Alizade M. Kernicterus in severe neonatal hyperbilirubinemia.
B Boskabadi H, Maamouri G, Mafinejad S, Rezagholizadeh F. Clinical course and prognosis of hemolytic jaundice in neonates in North East of Iran. Maced J Med Sci. 2011 Dec 1;4(4):403-7.
Abbas SH, Nafea LT, Abbas RS. Prevalence of ABO Incompatibility and its effect on Neonates Hyperbilirubinemia. Research Journal of Pharmacy and Technology. 2020;13(1):141-6.
Khurana R, Batra P, Faridi MM, Khan N. Revisiting ABO incompatibility as a risk factor for significant neonatal hyperbilirubinemia. Tropical doctor. 2019 Jul;49(3):201-4.
Yaseen H, Khalaf M, Rashid N, Darwich M. Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with ABO incompatibility and positive Coombs' test?. Journal of perinatology. 2005 Sep;25(9):590-4.
Boskabadi H, Sezavar M, Zakerihamidi M. Evaluation of neonatal jaundice based on the severity of hyperbilirubinemia. Journal of Clinical Neonatology. 2020 Jan 1;9(1):46-51.
Kaplan M, Bromiker R, Hammerman C. Hyperbilirubinemia, hemolysis, and increased bilirubin neurotoxicity. InSeminars in perinatology 2014 Nov 1 (Vol. 38, No. 7, pp. 429-437). WB Saunders.
Shahshahani S, Vameghi R, Azari N, Sajedi F, Kazemnejad A. Validity and reliability determination of Denver developmental screening test-II in 0-6 year–olds in Tehran. Iranian journal of pediatrics. 2010 Sep;20(3):313.
Akgül S, Korkmaz A, Yiğit S, Yurdakök M. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter. Turk J Pediatr. 2013 Sep 1;55(5):506-9.
Sarici SU, Yurdakök M, Serdar MA, Oran O, Erdem G, Tekinalp G, Yigit S. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Pediatrics. 2002 Apr 1;109(4):e53-.
Weng YH, Chiu YW. Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility. Chang Gung Med J. 2009 Jul 1;32(4):400-8.
Dillon A, Chaudhari T, Crispin P, Shadbolt B, Kent A. Has anti‐D prophylaxis increased the rate of positive direct antiglobulin test results and can the direct antiglobulin test predict need for phototherapy in Rh/ABO incompatibility?. Journal of paediatrics and child health. 2011 Jan;47(1‐2):40-3.
Kaini NR, Chaudhary D, Adhikary V, Bhattacharya S, Lamsal M. Overview of cases and prevalence of jaundice in neonatal intensive care unit. Nepal Medical College journal: NMCJ. 2006 Jun 1;8(2):133-5.
Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. Cmaj. 2006 Sep 12;175(6):587-90.
Shah VA, Yeo CL. Massive acute haemolysis and severe neonatal hyperbilirubinemia in glucose‐6‐phosphate dehydrogenase‐deficient preterm triplets. Journal of paediatrics and child health. 2007 May;43(5):411-3.
Bhutani VK, Maisels MJ, Stark AR, Buonocore G. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants≥ 35 weeks gestation. Neonatology. 2008 Jan 17;94(1):63-7.
Arun Babu T, Bhat B V, Joseph NM. Association between peak serum bilirubin and neurodevelopmental outcomes in term babies with hyperbilirubinemia. The Indian Journal of Pediatrics. 2012 Feb;79:202-6.
Rasul CH, Hasan MA, Yasmin F. Outcome of neonatal hyperbilirubinemia in a tertiary care hospital in Bangladesh. The Malaysian journal of medical sciences: MJMS. 2010 Apr;17(2):40.
Rasul CH, Hasan MA, Yasmin F. Outcome of neonatal hyperbilirubinemia in a tertiary care hospital in Bangladesh. The Malaysian journal of medical sciences: MJMS. 2010 Apr;17(2):40.
Maisels MJ. Managing the jaundiced newborn: a persistent challenge. Cmaj. 2015 Mar 17;187(5):335-43.
Shekari S, Farsi F, Ashrafzadeh F, Imannezhad S, Niazi AS, Kamali S. Transient blindness due to mild reversible encephalopathy in a 7‐year‐old boy. Clinical Case Reports. 2024 Feb;12(2):e8493.
- Abstract Viewed: 2 times